In an era of increasingly bespoke healthcare, Elizabeth Philp has become a leading force of innovation, notably in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a drive to make bespoke medications more obtainable, disrupting the standard one-size-fits-all approach